Knockdown of long noncoding RNA DLX6-AS1 inhibits migration and invasion of thyroid cancer cells by upregulating UPF1

Z-B Zhong1, Y-J Wu, J-N Luo

  • 1Department of Head and Neck Cancer Radiation Therapy, Harbin Medical University Cancer Hospital, Harbin, China. gexiaofeng121@163.com.

Abstract

Insights

Long non-coding RNA DLX6-AS1 promotes thyroid cancer (TC) progression. Inhibiting DLX6-AS1 suppresses TC cell migration and invasion by upregulating UPF1, suggesting DLX6-AS1 as a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • RNA Biology

Background:

  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their critical roles in cancer development.
  • The specific involvement of lncRNA DLX6 antisense RNA 1 (DLX6-AS1) in thyroid cancer (TC) pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the role of DLX6-AS1 in thyroid cancer progression.
  • To explore the underlying molecular mechanisms by which DLX6-AS1 influences TC development.

Main Methods:

  • Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to assess DLX6-AS1 expression in TC tissues and cells.
  • In vitro assays (Transwell, wound healing) to evaluate cell migration and invasion.
  • Western blot to analyze protein expression, including UPF1.
  • In vivo studies to confirm the functional role of DLX6-AS1 in tumor metastasis.

Main Results:

  • DLX6-AS1 expression was significantly elevated in TC tissues compared to normal tissues.
  • Knockdown of DLX6-AS1 inhibited TC cell migration and invasion in vitro.
  • DLX6-AS1 knockdown led to increased mRNA and protein expression of UPF1.
  • UPF1 expression was negatively correlated with DLX6-AS1 levels in TC tissues.
  • In vivo, DLX6-AS1 knockdown significantly suppressed tumor metastasis.

Conclusions:

  • DLX6-AS1 promotes thyroid cancer progression by enhancing cell migration and invasion.
  • The mechanism involves the downregulation of UPF1.
  • Targeting DLX6-AS1 represents a potential therapeutic strategy for thyroid cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.0K